Ashland provides a diverse range of components for formulating effective pharmaceutical excipients. Our collection of cellulose-based polymers (HPMC, HPC, CMC, HEC) is expanding, and we are enhancing our excipient options for injectables/biologics, with the potential for customization, and emphasizing on film coatings. Our pharmaceutical portfolio encompasses ingredients for oral solid dosage, liquid dosage, controlled release functionality, coatings, disintegrants, binders, and now, injectables, positioning it as the core strength of Ashland.
Ashland Industries Europe
Headquarters
Switzerland